DNA vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
View Patent ↗A method of eliciting an immune response in an organism comprising: providing an unprocessed rolling circle amplification (RCA) product; and administering an effective amount of the unprocessed RCA product to the organism to elicit the immune response, wherein the unprocessed RCA product is prepared from a circular nucleic acid template comprising at least one promoter sequence, and at least one target sequence. A vaccine comprising unprocessed RCA product is also provided and methods for making the same.
1. A method of eliciting an immune response to an antigen in a mammal comprising:
providing an unprocessed rolling circle amplification (RCA) product and
administering an effective amount of the unprocessed RCA product to the mammal to elicit the immune response to the antigen,
wherein the unprocessed RCA product is not deliberately or intentionally cleaved, circularized, and/or supercoiled and is prepared from a circular nucleic acid template comprising at least one promoter sequence and at least one target sequence, wherein the unprocessed RCA product comprises a tandem repeat nucleic acid sequence and the at least one target sequence codes for the antigen.
2. The method of claim 1 , wherein the antigen is a surface antigen of a bacterium, a virus, a fungus, a parasite, or of a tumor-associated antigen.
3. The method of claim 1 , wherein the at least one target sequence is a synthetic sequence.
4. The method of claim 3 , wherein the synthetic sequence codes for the antigen.
5. The method of claim 1 , wherein the circular nucleic acid template consists essentially of at least two target sequences each coding for a different antigen, wherein at least one antigen is capable of eliciting the immune response in the mammal.
6. The method of claim 1 , wherein the circular nucleic acid template is selected from the group consisting of double-stranded DNA, single-stranded DNA, and RNA.